GOLIMUMAB SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION AND FATIGUE IN RA PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF AGENTS: RESULTS FROM THE GO-AFTER STUDY
Main Authors: | Kay, J, Wordsworth, P, Doyle, M, Smolen, J, Buchanan, J, Matteson, E, Hsia, E, Landewe, R, Zhou, Y, Shreekant, P, Rahman, M, Investigators, GO-AFTER |
---|---|
Format: | Conference item |
Published: |
2010
|
Similar Items
-
GOLIMUMAB, A HUMAN TNF-ALPHA mu ONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY)
by: Wordsworth, P, et al.
Published: (2009) -
GOLIMUMAB IS EFFICACIOUS IN ANTI-TNF EXPERIENCED PTS WITH ACTIVE RA REGARDLESS OF TYPE OF AGENT OR REASON FOR DISCONTINUATION OF PRIOR ANTI-TNF: GO-AFTER STUDY
by: Smolen, J, et al.
Published: (2010) -
GOLIMUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Wordsworth, P, et al.
Published: (2009) -
Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.
by: Taylor, P, et al.
Published: (2011) -
Are TNF inhibitors still the agent of choice for RA?
by: Taylor, PC
Published: (2023)